Stay Alert for Safety Concerns With Picato for Actinic Keratosis

September 2020

Health Canada is warning about an increased risk of skin cancer in patients using Picato gel (ingenol mebutate) for actinic keratosis.

These thick, hard, and scaly skin patches from chronic sun exposure can progress to squamous cell carcinoma.

The new warning is based on numerous clinical trials and case reports linking the use of Picato with skin cancer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Practice Help Patients Tolerate Masks in Light of COVID-19
Probiotics Clarify When Probiotics May Be Helpful for GI Problems
Influenza Answer Questions About the New Flucelvax Quad Flu Vaccine
Dermatology Stay Alert for Safety Concerns With Picato for Actinic Keratosis
Antithrombotics Help Manage Minor Bleeds From Antithrombotics
Iron Point Out Limitations of Alternate-Day Iron Dosing
Smoking Cessation Optimize Use of Champix for Smoking Cessation
Cannabinoids Educate Teens About Cannabis Risks and Help Them Stop
Inhalers Help Patients Troubleshoot Clogged or Empty Inhalers
Med Safety Notify Patients That Brand-Name Coumadin Is Discontinued